Galectin Therapeutics Inc (GALT)
3.46
-0.04
(-1.14%)
USD |
NASDAQ |
Apr 26, 16:00
3.46
0.00 (0.00%)
After-Hours: 20:00
Galectin Therapeutics Total Return Level: 3.50 for April 25, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
April 25, 2024 | 3.50 |
April 24, 2024 | 3.29 |
April 23, 2024 | 3.38 |
April 22, 2024 | 3.06 |
April 19, 2024 | 3.37 |
April 18, 2024 | 3.38 |
April 17, 2024 | 3.38 |
April 16, 2024 | 3.40 |
April 15, 2024 | 3.91 |
April 12, 2024 | 3.97 |
April 11, 2024 | 4.20 |
April 10, 2024 | 3.82 |
April 09, 2024 | 3.94 |
April 08, 2024 | 3.74 |
April 05, 2024 | 3.73 |
April 04, 2024 | 3.00 |
April 03, 2024 | 2.85 |
April 02, 2024 | 2.51 |
April 01, 2024 | 2.44 |
March 28, 2024 | 2.39 |
March 27, 2024 | 2.41 |
March 26, 2024 | 2.37 |
March 25, 2024 | 2.33 |
March 22, 2024 | 2.44 |
March 21, 2024 | 2.44 |
Date | Value |
---|---|
March 20, 2024 | 2.20 |
March 19, 2024 | 2.10 |
March 18, 2024 | 2.14 |
March 15, 2024 | 2.06 |
March 14, 2024 | 1.98 |
March 13, 2024 | 1.98 |
March 12, 2024 | 1.97 |
March 11, 2024 | 2.01 |
March 08, 2024 | 2.04 |
March 07, 2024 | 2.09 |
March 06, 2024 | 2.08 |
March 05, 2024 | 2.06 |
March 04, 2024 | 1.99 |
March 01, 2024 | 1.93 |
February 29, 2024 | 1.955 |
February 28, 2024 | 1.89 |
February 27, 2024 | 1.86 |
February 26, 2024 | 1.88 |
February 23, 2024 | 1.88 |
February 22, 2024 | 1.78 |
February 21, 2024 | 1.86 |
February 20, 2024 | 1.86 |
February 16, 2024 | 1.74 |
February 15, 2024 | 1.75 |
February 14, 2024 | 1.73 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
1.03
Minimum
Dec 28 2022
5.10
Maximum
Apr 28 2021
2.447
Average
2.23
Median
Jan 08 2021
Total Return Level Benchmarks
Madrigal Pharmaceuticals Inc | 194.38 |
Viking Therapeutics Inc | 68.86 |
89bio Inc | 8.25 |
Terns Pharmaceuticals Inc | 4.64 |
Enanta Pharmaceuticals Inc | 12.48 |